Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)
Clinical trial NCT00574132 · COMPLETED
Trial details
- NCT number
- NCT00574132
- Sponsor
- JANSSEN Alzheimer Immunotherapy Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2012-06-01
- Enrollment
- 1331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.